Prilenia Therapeutics
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- $116M
Investors
- 10
About Prilenia Therapeutics
V.V. specializes in creating therapies for neurodegenerative diseases.000 mn.Prilenia Therapeutics is a clinical-stage biotechnology company primarily focused on developing innovative therapies for neurodegenerative diseases, with a particular emphasis on Huntington's disease and Amyotrophic Lateral Sclerosis (ALS). Their flagship product, Pridopidine, is designed to address the underlying mechanisms of these conditions by modulating the activity of certain proteins involved in neuronal health. The company aims to enhance the quality of life for patients and their families affected by these debilitating diseases. Pridopidine has undergone various stages of clinical trials, with its most promising results showcasing potential neuroprotective and symptomatic benefits.Prilenia Therapeutics generates revenue primarily through partnerships and collaborations within the healthcare sector, focusing on the development and commercialization of its therapies. The structure of their transactions typically involves agreements with pharmaceutical companies for the co-development and potential distribution of their products, including Pridopidine. Their revenue model may include milestone payments associated with clinical trial achievements and royalties from future sales of their therapies.Prilenia Therapeutics is actively working on the development of new products to enhance their therapeutic offerings.
Who invested in Prilenia Therapeutics
10 investors across 3 rounds
See all investors in Prilenia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prilenia Therapeutics
Who invested in Prilenia Therapeutics?
Prilenia Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prilenia Therapeutics raised?
Prilenia Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Prilenia Therapeutics last raise money?
Prilenia Therapeutics's most recent round on record is a Series B, in Apr 2022.
What does Prilenia Therapeutics do?
Prilenia Therapeutics is a biotechnology company.
Where is Prilenia Therapeutics headquartered?
Prilenia Therapeutics is headquartered in Herzliya, Israel.
Which VCs invest in companies like Prilenia Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Prilenia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Prilenia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.